Publications
Orazi A, OMalley DP. Bone Marrow Biopsy Immunohistochemistry: An Overview. Adv Med Professionals Lab, 12:22-25, 2003.
Ponzoni M, Savage DG, Ferreri AJM, Pruneri G, Viale G, Servida P, Bertolini F and Orazi A. Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining. Mod Pathol, 17:1513-1520, 2004.
O Malley DP, Vance GH, Orazi A. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Trisomy 12 and Focal Cyclin D1 Expression: A Potential Pitfall. Arch PathLab Med, 129:92-95, 2005.
Khalaf WF, White H, Wenning MJ, Orazi A, Kapur R, Ingram DA.K-Ras is essential for normal fetal liver erythropoiesis. Blood, 105:3538-3541, 2005.
Thiele J, Kvasnicka HM, Facchetti F, Franco V, van Der Walt J, Orazi A. European consensus for grading of bone marrow fibrosis and assessment of cellularity, Haematologica, 90:1128-1132, 2005.
Thiele J, Kvasnicka HM, Orazi A. Bone marrow histopathology in myeloproliferative disorders current diagnostic approach. Seminars in Hematology, 42:184-195, 2005.
OMalley DP, Sen J, Juliar BE, Orazi A. Evaluation of stroma in human immunodeficiency virus/acquired immunodeficiency syndrome-affected bone marrows and correlation with CD4 counts. Arch Pathol Lab Med, 129:1137-40, 2005.
OMalley DP, Kim YS, Perkins SL, Baldridge L, Juliar BE, Orazi A. Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders. Mod Pathol, 18:1550-61, 2005.
OMalley DP, Orazi A, Wang M, Cheng L. Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia. Mod Pathol, 18:1562-8, 2005.
Orazi A, O'Malley DP, Jiang J, Vance GH, Thomas J, Czader M, Fang W, An C, Banks PM. Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia. Mod Pathol, 18:603-614, 2005.
OMalley DP, Orazi A. Terminal deoxynucleotidyl transferase-positive cells in spleen, appendix, and brachial cleft cysts in pediatric patients. Haematologica, 91(8):1139-1140, 2006.
Orazi A, Chiu R, OMalley DP, Czader M, Allen SL, An C, Vance G. Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology. Mod Pathol, 19:1536-1545, 2006.
Al-Abbadi MA, Hattab EM, Tarawneh MS, Amr SS, Ulbright SS, Orazi A. Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-celllike subgroup: a study of 18 cases. Mod Pathol, 19:1521-1527, 2006.
Orazi A. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/ myeloproliferative diseases. Pathobiology. 2007;74(2):97-114.
Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA, Barosi G, Verstovsek S, Brgegard G, Mesa R, Reilly JT, Gisslinger H, Vannucchi A, Cervantes F, Finazzi G, Hoffman R, Gilliland DG, Bloomfield CD, Vardiman JW. Proposals for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: From an ad hoc international expert panel. Blood. 2007 Aug 15;110(4):1092-7.
OMalley DP, Orazi A, Dunphy CH, Coleman BR, Marks RA, Wang M, Cheng L. Loss of heterozygosity identifies genetic changes in chronic myeloid disorders, including myeloproliferative disorders, myelodysplastic syndromes and chronic myelomonocytic leukemia. Mod Pathol 2007 Nov;20(11):1166-71.
Orazi A, Germing U. The Myelodysplastic/Myeloproliferative Neoplasms: Myeloproliferative Diseases with Dysplastic Features. Leukemia. 2008 Jul;22(7):1308-19.
Fend F, Horn T, Koch I, Vela T, Orazi A. Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative myeloid neoplasm. Leuk Res. 2008 Jun 12. [Epub ahead of print].
